MyFinsight
Home
Blog
About
Cash and cash
equivalents
$225,491,985
(1837.56%↑ Y/Y)
Short-term investments
$6,615,168
Prepaid expenses and
other current assets
$1,682,918
(144.78%↑ Y/Y)
Total current assets
$233,790,071
(1796.81%↑ Y/Y)
Property and equipment,
net
$2,358,428
(5.69%↑ Y/Y)
Long-term investments
$2,052,142
Right-of-use assets, net
$887,837
(-6.26%↓ Y/Y)
Other assets
$20,418
(0.00%↑ Y/Y)
Total assets
$239,108,896
(1429.31%↑ Y/Y)
Total liabilities and
stockholders equity
$239,108,896
(1429.31%↑ Y/Y)
Total stockholders
equity
$228,916,553
(4819.73%↑ Y/Y)
Total liabilities
$10,192,343
(-7.19%↓ Y/Y)
Accumulated deficit
-$126,106,973
(-46.31%↓ Y/Y)
Treasury stock at cost,
72,363 shares as of june...
$99,963
(0.00%↑ Y/Y)
Additional paid-in capital
$354,997,609
(290.64%↑ Y/Y)
Total current
liabilities
$9,301,705
(-7.07%↓ Y/Y)
Operating lease liability
long term
$890,638
(-8.40%↓ Y/Y)
Accumulated other
comprehensive income
$118,720
(82.56%↑ Y/Y)
Common stock, 0.0001
par value...
$7,160
(151.49%↑ Y/Y)
Accounts payable and
accrued expenses
$9,190,591
(-7.53%↓ Y/Y)
Operating lease liability
- current
$111,114
(57.68%↑ Y/Y)
Back
Back
Balance Sheet
Immix Biopharma, Inc. (IMMX)
Immix Biopharma, Inc. (IMMX)
source: myfinsight.com